The role of cAMP in mucosal adjuvanticity of Escherichia coli heat- labile enterotoxin (LT)

Vaccine

Volumn 18, Issue 1-2, 1999, Pages 38-49

  Cheng, Elly ^a   Cárdenas Freytag, Lucia ^a   Clements, John D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvants; Cytokines; LT; Mucosal vaccines

Indexed keywords

ADJUVANT; CHOLERA TOXIN; CYCLIC AMP; ENTEROTOXIN; PROTEINASE; TETANUS TOXOID;

ARTICLE; CELL STRAIN CACO 2; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNIZATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; VIBRIO CHOLERAE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BACTERIAL TOXINS; CACO-2 CELLS; CYCLIC AMP; CYTOKINES; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUTAGENESIS, SITE-DIRECTED; STRUCTURE-ACTIVITY RELATIONSHIP; TETANUS TOXOID;

EID: 0344200089     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00168-1     Document Type: Article

References (46)

1. Burnette W.N., Mar V.L., Platler B.W., Schlotterbeck J.D., McGinley M.D., Stoney K.S., Rhode M.F., Kaslow H.R. Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity. Infect Immun. 59:1991;4266-4270.
2. Cárdenas-Freytag L., Cheng E., Mayeux P., Domer J.E., J D.C. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect Immun. 67:1999;826-833.
3. Cassel D., Pfeuffer T. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci. 75:1978;2669-2673.
4. Chong C., Friberg M., Clements J.D. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine. 16:1998;732-740.
5. Clements J.D., Hartzog N.M., Lyon F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine. 6:1988;269-277.
6. Czerkinsky C., Russell M.W., Lycke N., Lindblad M., Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun. 57:1989;1072-1077.
7. de Haan L., Feil I.K., Verweij W.R., Holtrop M., Hol W.G., Agsteribbe E., Wilschut J. Mutational analysis of the role of ADP-ribosylation activity and GM1- binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin. Eur J Immunol. 28:1998;1243-1250.
8. de Haan L., Verweij W.R., Feil I.K., Lijnema T.H., Hol W.G.J., Agsteribbe E., Wilschut J. Mutants of Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect Immun. 64:1996;5413-5416.
9. Dickinson B.L., Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun. 63:1995;1617-1623.
10. Domenighini M., Magagnoli C., Pizza M., Rappuoli R. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. Mol Microbiol. 14:1994;41-50.
11. Douce G., Fontana M., Pizza M., Rappuoli R., Dougan G. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect Immun. 65:1997;2821-2828.
12. Douce G., Turcotte C., Cropley I., Roberts M., Pizza M., Domenghini M., Rappuoli R., Dougan G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci. 92:1995;1644-1648.
13. Elson C.O. Cholera toxin and its subunits as potential oral adjuvants. Immunol Today. 146:1989;29-33.
14. Evans D.G., Evans D.J. Jr., Gorbach S.L. Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun. 8:1973;731-735.
15. Fishman P.H. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol. 69:1982;85-97.
16. Gill D.M. Involvement of nicotinamide adenine dinucleotide in the action of cholera toxin in vitro. Proc Natl Acad Sci. 72:1975;2064-2068.
17. Gill D.M., Richardson S.H. Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin. J Infect Diseases. 141:1980;64-70.
18. Giuliani M.M., Del Giudice G., Giannelli V., Dougan G., Douce G., Rappuoli R., Pizza M. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med. 187:1998;1123-1132.
19. Grant C.C.R., Messer R.J., Cieplak W. Jr. Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin. InfectImmun. 62:1994;4270-4278.
20. Harford S., Dykes C.W., Hobden A.N., Read M.J., Halliday I.J. Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene. Eur J Biochem. 183:1989;311-316.
21. Häse C.C., Thai L.S., Boesman-Finkelstein M., Mar V.L., Burnette W.N., Kaslow H.R., Stevens L.A., Moss J., Finkelstein R.A. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs. Infect Immun. 62:1994;3051-3057.
22. Katz J.M., Lu X., Galphin J.C., Clements J.D. Heat-labile enterotoxin from Escherichia coli as an adjuvant for oral influenza vaccination. Brown L.E., Hampson A.W., Webster R.G. Options for the control of influenza, vol. III. 1996;292-297 Elsevier Science, New York.
23. Komase K., Tamura S., Matsuo K., Watanabe K., Hattori N., Odaka A., Suzuki Y., Kurata T., Aizawa C. Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine. Vaccine. 16:1998;248-254.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (London). 227:1970;680-685.
25. Levine M.M., Kaper J.B., Black R.E., Clements M.L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Mircobiol Rev. 47:1983;510-550.
26. Lobet Y., Cluff C.W., Cieplak W. Jr. Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin. Infect Immun. 59:1991;2870-2879.
27. Lycke N., Tsuji T., Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol. 22:1992;2277-2281.
28. Mason H.S., Haq T.A., Clements J.D., Arntzen C.J. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 16:1998;1336-1343.
29. Mekalanos J.J., Collier R.J., Romig W.R. Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J Biol Chem. 254:1979;5855-5861.
30. Merritt E.A., Sarfaty S., Pizza M., Domenighini M., Rappuoli R., Hol W.G. Mutation of a buried residue causes loss of activity but no conformational change in the heat-labile enterotoxin of Escherichia coli. Nature Struct Biol. 2:1995;269-272.
31. Moss J., Osborne J.C. Jr., Fishman P.H., Nakaya S., Robertson D.C. Escherichia coli heat-labile enterotoxin. Ganglioside specificity and ADP-ribosyltransferase activity. J Biol Chem. 256:1981;12861-12865.
32. Moss J., Stanley S.J., Lin M.C. NAD glycohydrolase and ADP-ribosyltransferase activities are intrinsic to the A1 peptide of choleragen. J Biol Chem. 254:1979;11993-11999.
33. Moss J., Stanley S.J., Vaughan M., Tsuji T. Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution. J Biol Chem. 268:1993;6383-6387.
34. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge [in process citation]. J Virol. 72:1998;3390-3393.
35. Pizza M., Domenighini M., Hol W., Giannelli V., Fontana M.R., Giuliani M.M., Magagnoli C., Peppoloni S., Manetti R., Rappuoli R. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microbiol. 14:1994;51-60.
36. Richardson S.H., Giles J.C., Kriger K.S. Sealed adult mice: a new model for enterotoxin evaluation. Infect Immun. 43:1984;482-486.
37. Sack D.A., Sack R.B. Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun. 11:1975;334-336.
38. Sixma T.K., Kalk K.H., van Zanten B.A.M., Dauter Z., Kingma J., Witholt B., Hol W.G.J. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J Mol Biol. 230:1993;890-918.
39. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A.M., Witholt B., Hol W.G.J. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature (London). 351:1991;371-377.
40. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev. 56:1992;622-647.
41. Tamura S., Yamanaka A., Shimohara M., Tomita T., Komase K., Tsuda Y., Suzuki Y., Nagamine T., Kawahara K., Danbara H., Aizawa C., Oya A., Kurata T. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine. 12:1994;419-426.
42. Tsuji T., Inoue T., Miyama A., Noda M. Glutamic acid-112 of the A subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP-ribosyltransferase activity. FEBS Lett. 291:1991;319-321.
43. Tsuji T., Inoue T., Miyama A., Okamoto K., Honda T., Miwatani T. A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in loss of its toxic activitiy. J Biol Chem. 265:1990;22520-22525.
44. Tsuji T., Yokochi T., Kamiya H., Kawamoto Y., Miyama A., Asano Y. Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action. Immunology. 90:1997;176-182.
45. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Yamamoto M., Fujihashi K., VanGinkel F.W., Noda M., Takeda Y., McGhee J.R. A nontoxic mutant of cholera toxin elicits Th-2 type responses for enhanced mucosal immunity. Proc Natl Acad Sci. 94:1997;5267-5272.
46. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Yamamoto M., Fujihashi K., Noda M., Kiyono H., McGhee J.R. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med. 185:1997;1203-1210.